Broader Economy Weighs Down LS Tools, MDx Stocks | GenomeWeb

NEW YORK (GenomeWeb) – A tumultuous global stock market weighed heavily on the shares of companies in the omics life science tools and molecular diagnostics space in August as the GenomeWeb Index fell nearly 8 percent month over month. 

The number of decliners outnumbered the number of gainers 25 to seven in August, and the index also fell more sharply than the Dow Jones Industrial Average and the Nasdaq Composite, both of which fell about 7 percent month over month. It beat the Nasdaq Biotechnology Index, however, which saw an 11 percent contraction in August. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.